HUP9901474A2 - Szekvenciális ösztrogén/progeszteron-antagonista kombináció hormonhelyettesítő terápiához - Google Patents
Szekvenciális ösztrogén/progeszteron-antagonista kombináció hormonhelyettesítő terápiáhozInfo
- Publication number
- HUP9901474A2 HUP9901474A2 HU9901474A HUP9901474A HUP9901474A2 HU P9901474 A2 HUP9901474 A2 HU P9901474A2 HU 9901474 A HU9901474 A HU 9901474A HU P9901474 A HUP9901474 A HU P9901474A HU P9901474 A2 HUP9901474 A2 HU P9901474A2
- Authority
- HU
- Hungary
- Prior art keywords
- replacement therapy
- progesterone antagonist
- sequential
- oestrogen
- dose units
- Prior art date
Links
- 239000000262 estrogen Substances 0.000 title abstract 3
- 239000000044 progesterone antagonist Substances 0.000 title abstract 3
- 238000002657 hormone replacement therapy Methods 0.000 title 1
- 229940011871 estrogen Drugs 0.000 abstract 2
- 238000009256 replacement therapy Methods 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 239000004575 stone Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
A találmány tárgya gyógyszerkészítmény, amely egy ösztrőgén egyesdózisegységeit és egy kőmpetitív prőgeszterőnantagőnista egyesdózisegységeit kőmbinációban tartalmazza ezek elkülönített,szekvenciális adagőlásáhőz, tővábbá egy hőrmőnhelyettesítő terápiáhőzhasználható csőmag, amely egy ösztrőgén egyes dózisegységeit és egykőmpetitív prőgeszterőnantagőnista egyes dózisegységeit tartalmazzaezek elkülönített, szekvenciális adagőlásáhőz, valamint a fentnevezett gyógyszer hőrmőnhelyettesítő terápiára való alkalmazása. ŕ
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19610635A DE19610635A1 (de) | 1996-03-11 | 1996-03-11 | Sequentielle Estrogen/Progesteronantagonist-Kombination für die Hormonersatz-Therapie |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP9901474A2 true HUP9901474A2 (hu) | 1999-09-28 |
HUP9901474A3 HUP9901474A3 (en) | 2000-02-28 |
Family
ID=7788657
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9901474A HUP9901474A3 (en) | 1996-03-11 | 1997-03-11 | Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0889727B1 (hu) |
JP (1) | JP2000506175A (hu) |
KR (1) | KR19990087672A (hu) |
AT (1) | ATE319454T1 (hu) |
AU (1) | AU2691197A (hu) |
BR (1) | BR9708162A (hu) |
CA (1) | CA2248841C (hu) |
DE (2) | DE19610635A1 (hu) |
DK (1) | DK0889727T3 (hu) |
ES (1) | ES2260792T3 (hu) |
HU (1) | HUP9901474A3 (hu) |
IL (1) | IL126176A (hu) |
NO (1) | NO324613B1 (hu) |
PL (1) | PL328809A1 (hu) |
PT (1) | PT889727E (hu) |
WO (1) | WO1997033589A1 (hu) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19834931A1 (de) * | 1998-07-28 | 2000-02-24 | Jenapharm Gmbh | Verwendung von biogenen Estrogenen zur Hormonsubstitutionstherapie |
CO5200773A1 (es) * | 1999-08-31 | 2002-09-27 | Jenapharm Gmbh And Co Kg | Mesoprogestinas (moduladores de receptores para progestero- na) como componente de composiciones utilizadas para la terapia de sustitucion hormonal (trh) |
US7629334B1 (en) | 1999-08-31 | 2009-12-08 | Bayer Schering Pharma Aktiengesellschaft | Mesoprogrestins (progesterone receptor modulations) as a component of compositions for hormone replacement therapy (HRT) |
IL145838A (en) * | 2000-10-16 | 2008-11-03 | Pfizer Prod Inc | Use of an estrogen agonist / antagonist to produce a drug for the treatment of vaginitis |
ES2233570T3 (es) * | 2000-11-30 | 2005-06-16 | Pfizer Products Inc. | Composicion que contiene agonistas/antagosnistas de estrogenos y testosterona para tratar un descenso en el nivel de la hormona testosterona. |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5468736A (en) * | 1993-02-25 | 1995-11-21 | The Medical College Of Hampton Road | Hormone replacement therapy |
-
1996
- 1996-03-11 DE DE19610635A patent/DE19610635A1/de not_active Ceased
-
1997
- 1997-03-11 JP JP9532200A patent/JP2000506175A/ja not_active Ceased
- 1997-03-11 AU AU26911/97A patent/AU2691197A/en not_active Abandoned
- 1997-03-11 DK DK97920535T patent/DK0889727T3/da active
- 1997-03-11 KR KR1019980707136A patent/KR19990087672A/ko not_active Application Discontinuation
- 1997-03-11 CA CA002248841A patent/CA2248841C/en not_active Expired - Fee Related
- 1997-03-11 WO PCT/DE1997/000580 patent/WO1997033589A1/de active IP Right Grant
- 1997-03-11 HU HU9901474A patent/HUP9901474A3/hu unknown
- 1997-03-11 ES ES97920535T patent/ES2260792T3/es not_active Expired - Lifetime
- 1997-03-11 DE DE59712593T patent/DE59712593D1/de not_active Expired - Fee Related
- 1997-03-11 IL IL12617697A patent/IL126176A/en not_active IP Right Cessation
- 1997-03-11 EP EP97920535A patent/EP0889727B1/de not_active Expired - Lifetime
- 1997-03-11 PL PL97328809A patent/PL328809A1/xx unknown
- 1997-03-11 BR BR9708162A patent/BR9708162A/pt not_active Application Discontinuation
- 1997-03-11 AT AT97920535T patent/ATE319454T1/de not_active IP Right Cessation
- 1997-03-11 PT PT97920535T patent/PT889727E/pt unknown
-
1998
- 1998-09-10 NO NO19984166A patent/NO324613B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
IL126176A (en) | 2004-12-15 |
NO324613B1 (no) | 2007-11-26 |
IL126176A0 (en) | 1999-05-09 |
DK0889727T3 (da) | 2006-07-03 |
WO1997033589A1 (de) | 1997-09-18 |
NO984166L (no) | 1998-09-10 |
HUP9901474A3 (en) | 2000-02-28 |
PT889727E (pt) | 2006-07-31 |
BR9708162A (pt) | 1999-07-27 |
PL328809A1 (en) | 1999-02-15 |
EP0889727A1 (de) | 1999-01-13 |
CA2248841C (en) | 2008-07-22 |
JP2000506175A (ja) | 2000-05-23 |
ATE319454T1 (de) | 2006-03-15 |
AU2691197A (en) | 1997-10-01 |
DE19610635A1 (de) | 1997-09-18 |
DE59712593D1 (de) | 2006-05-04 |
CA2248841A1 (en) | 1997-09-18 |
ES2260792T3 (es) | 2006-11-01 |
KR19990087672A (ko) | 1999-12-27 |
EP0889727B1 (de) | 2006-03-08 |
NO984166D0 (no) | 1998-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9709934A (pt) | Kit de terapia de reposição hormonal e/ou contraceptivo uso de unidades de dosagem diária consistindo essecialmente de um progestogênio e processo de preparação de um sistema de liberação de droga | |
EE05129B1 (et) | Konjugeeritud strogeenide ja medroksprogesteroonatsetaadi kasutamine, farmatseutiline kompositsioon, doseerimishik ja pakend | |
AU3254395A (en) | Use of a combination product that contains a competitive progesterone antagonist and a gestagen for the production of a pharmaceutical agent for treating endometriosis or leiomyomata uteri | |
CO5261567A1 (es) | Uso de sulfamatos estrogenos biogenicos en una terapia de reemplazo de hormonas | |
UA41401C2 (uk) | Фармацевтичний контрацептивний комбінований препарат | |
EE200100256A (et) | Ravimi manustamise vahend, eriti progestiinide jaöstrogeenide manustamiseks | |
HUP9900612A2 (hu) | Új hormonális gyógyászati készítmények, valamint a készítmények alkalmazása ösztrogénpótlásra | |
HUP0203721A2 (hu) | Új hormonkészítmény és alkalmazása | |
BR0008076A (pt) | 16-hidroxiestratrienos como estrogênios de efeito seletivo | |
BG101427A (en) | Competitive progesterone antagonists for regulating female fertility as required | |
HUP9901474A2 (hu) | Szekvenciális ösztrogén/progeszteron-antagonista kombináció hormonhelyettesítő terápiához | |
CY1108648T1 (el) | Αναστολεας της αρωματασης σε μια δοση για την θεραπευτικη αντιμετωπιση της υπογόνιμοτήτας | |
NO20002526D0 (no) | Mellomprodukt med høyt legemiddelinnhold og orale doseringspreparater med modifisert frigivelse samt fremgangsmÕter for fremstilling derav | |
HUP0202741A2 (hu) | Méhen kívüli méhnyálkahártya-növekedés, krónikus medencefájdalom és petevezeték-elzáródás gyógyászati kezelésére alkalmas gyógyszerkészítmény és eljárás az előállítására | |
HUP0004461A2 (hu) | Apoliprotein B kiválasztást/mikroszomális trigliceridtranszfer-proteint gátló anyag alkalmazása gyógyászati készítmények előállítására és a fenti gyógyászati készítmények | |
ATE295169T1 (de) | Arzneimittel gegen infertilität, die mit endometriose assoziiert ist | |
JP2001513566A5 (hu) | ||
BR9912260A (pt) | Emplastro contendo um sistema terapêutico transdérmico e dose única para ministração | |
TH27339A (th) | ฮอร์โมนตัวใหม่ที่ใช้เป็นยาและประโยชน์ของมันในการรักษาภาวะขาดเอสโตเจน |